Search research articles
Contact Us
Filters
Showing results (241-250 of 332) with videos related to
Page
of 34
Sort By:
Journal of Neurochemistry
|
February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Kumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.
Experimental Neurology
|
November 29, 2019
The p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy
Ling-Yu Yang, Nigel H Greig, David Tweedie, et al.
Experimental Neurology
|
October 13, 2012
Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice
David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Geroscience
|
April 2, 2024
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease
Seong-Jin Yu, Yun Wang, Hui Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 27, 2007
Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy
Tadanobu Utsuki, Nao Uchimura, Mitsuru Irikura, et al.
CNS Neuroscience & Therapeutics
|
December 13, 2019
(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury
Nigel H Greig, Daniela Lecca, Shih-Chang Hsueh, et al.
Current Problems in Cardiology
|
December 24, 2025
Balancing hope and heart: An umbrella review of cardiotoxicity in immune checkpoint inhibitor cancer therapies
Yashendra Sethi, Saurabh Singhal, Apoorv Pratap Singh, et al.
Cell Transplantation
|
March 14, 2024
Pomalidomide Improves Motor Behavioral Deficits and Protects Cerebral Cortex and Striatum Against Neurodegeneration Through a Reduction of Oxidative/Nitrosative Damages and Neuroinflammation After Traumatic Brain Injury
Ya-Ni Huang, Nigel H Greig, Pen-Sen Huang, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 12, 2011
The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen
Jack T Rogers, Sohan Mikkilineni, Ippolita Cantuti-Castelvetri, et al.
JAMA Neurology
|
January 15, 2019
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, et al.
Page
of 34
Search research articles
Search
Showing results (241-250 of 332) with videos related to
Sort By:
Page
of 34
Journal of Neurochemistry
|
February 16, 2011
Targets for AD treatment: conflicting messages from γ-secretase inhibitors
Kumar Sambamurti, Nigel H Greig, Tadanobu Utsuki, et al.
Experimental Neurology
|
November 29, 2019
The p53 inactivators pifithrin-μ and pifithrin-α mitigate TBI-induced neuronal damage through regulation of oxidative stress, neuroinflammation, autophagy and mitophagy
Ling-Yu Yang, Nigel H Greig, David Tweedie, et al.
Experimental Neurology
|
October 13, 2012
Exendin-4, a glucagon-like peptide-1 receptor agonist prevents mTBI-induced changes in hippocampus gene expression and memory deficits in mice
David Tweedie, Lital Rachmany, Vardit Rubovitch, et al.
Geroscience
|
April 2, 2024
DPP-4 inhibitors sitagliptin and PF-00734,200 mitigate dopaminergic neurodegeneration, neuroinflammation and behavioral impairment in the rat 6-OHDA model of Parkinson's disease
Seong-Jin Yu, Yun Wang, Hui Shen, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
January 27, 2007
Preclinical investigation of the topical administration of phenserine: transdermal flux, cholinesterase inhibition, and cognitive efficacy
Tadanobu Utsuki, Nao Uchimura, Mitsuru Irikura, et al.
CNS Neuroscience & Therapeutics
|
December 13, 2019
(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury
Nigel H Greig, Daniela Lecca, Shih-Chang Hsueh, et al.
Current Problems in Cardiology
|
December 24, 2025
Balancing hope and heart: An umbrella review of cardiotoxicity in immune checkpoint inhibitor cancer therapies
Yashendra Sethi, Saurabh Singhal, Apoorv Pratap Singh, et al.
Cell Transplantation
|
March 14, 2024
Pomalidomide Improves Motor Behavioral Deficits and Protects Cerebral Cortex and Striatum Against Neurodegeneration Through a Reduction of Oxidative/Nitrosative Damages and Neuroinflammation After Traumatic Brain Injury
Ya-Ni Huang, Nigel H Greig, Pen-Sen Huang, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 12, 2011
The alpha-synuclein 5'untranslated region targeted translation blockers: anti-alpha synuclein efficacy of cardiac glycosides and Posiphen
Jack T Rogers, Sohan Mikkilineni, Ippolita Cantuti-Castelvetri, et al.
JAMA Neurology
|
January 15, 2019
Utility of Neuronal-Derived Exosomes to Examine Molecular Mechanisms That Affect Motor Function in Patients With Parkinson Disease: A Secondary Analysis of the Exenatide-PD Trial
Dilan Athauda, Seema Gulyani, Hanuma Kumar Karnati, et al.
Page
of 34